These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 10494185

  • 1. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T, Hawrylecka D, Skotnicki AB.
    Przegl Lek; 1999; 56 Suppl 1():62-6. PubMed ID: 10494185
    [Abstract] [Full Text] [Related]

  • 2. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 3. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 4. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 5. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [Abstract] [Full Text] [Related]

  • 6. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 7. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Dec; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic myelogenous leukemia.
    Giralt S, Kantarjian H, Talpaz M.
    Semin Oncol; 1995 Aug; 22(4):396-404. PubMed ID: 7638636
    [Abstract] [Full Text] [Related]

  • 10. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF, Fan ZP, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
    [Abstract] [Full Text] [Related]

  • 12. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
    Hatsuse M, Okano A, Okamoto A, Shimura K, Takahashi R, Hirai H, Ashihara E, Inaba T, Fujita N, Shimazaki C, Nakagawa M.
    Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
    [Abstract] [Full Text] [Related]

  • 13. [Developments in the treatment of patients with chronic myeloid leukemia].
    Cornelissen JJ, Löwenberg B.
    Ned Tijdschr Geneeskd; 1997 Oct 04; 141(40):1904-9. PubMed ID: 9550736
    [Abstract] [Full Text] [Related]

  • 14. Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine.
    Chalmers EA, Franklin IM, Kelsey S, Clarke R, Sproul AM, Goldstone AH, Hepplestone A, Watson W, Sharp S, Tansey P.
    Bone Marrow Transplant; 1994 Oct 04; 14 Suppl 3():S38-41. PubMed ID: 7697006
    [Abstract] [Full Text] [Related]

  • 15. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 04; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 16. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L.
    Ann Med; 2008 Jul 04; 40(6):444-55. PubMed ID: 18608121
    [Abstract] [Full Text] [Related]

  • 17. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.
    J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049
    [Abstract] [Full Text] [Related]

  • 18. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Jul 15; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 19. Chronic myelogenous leukemia: state of the art.
    Polli EE, Pozzoli E, Annaloro C.
    Ann Ital Med Int; 1991 Jul 15; 6(4 Pt 2):491-7. PubMed ID: 1840816
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M.
    Semin Oncol; 1994 Dec 15; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.